Evidence map›Paper›PMID 37652956›Full record

ArticleScientific reports2023

No increase in translocated chromosomal aberrations, an indicator of ionizing radiation exposure, in childhood thyroid cancer in Fukushima Prefecture.

Akira Sakai, Naohiro Tsuyama, Tetsuya Ohira, Misaki Sugai-Takahashi, Takashi Ohba, Yusuke Azami, Yoshiko Matsumoto, Iwadate Manabu, Satoshi Suzuki, Maki Sato and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Akira SakaiDepartment of Radiation Life Sciences, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan. sakira@fmu.ac.jp.
Naohiro TsuyamaDepartment of Radiation Life Sciences, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
Tetsuya OhiraDepartment of Epidemiology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Misaki Sugai-TakahashiDepartment of Radiation Life Sciences, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan.
Takashi OhbaDepartment of Radiological Sciences, Fukushima Medical University School of Health Sciences, Fukushima, Japan.
Yusuke AzamiDepartment of Radiation Oncology, Southern Tohoku General Hospital, Sendai, Japan.
Yoshiko MatsumotoDepartment of Thyroid and Endocrinology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Iwadate ManabuDepartment of Thyroid and Endocrinology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Satoshi SuzukiDepartment of Thyroid and Endocrinology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Maki SatoDepartment of Pediatrics, Fukushima Medical University School of Medicine, Fukushima, Japan.
Mitsuaki HosoyaDepartment of Pediatrics, Fukushima Medical University School of Medicine, Fukushima, Japan.
Tetsuo IshikawaDepartment of Radiation Physics and Chemistry, Fukushima Medical University School of Medicine, Fukushima, Japan.
Shinichi SuzukiDepartment of Thyroid Treatment, Fukushima Medical University School of Medicine, Fukushima, Japan.
Fukushima Medical University · JPSouthern Tohoku General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate the effects of radiation exposure due to the Fukushima nuclear power plant accident, following the disaster Fukushima Prefecture launched thyroid ultrasound examinations of residents who were generally younger than 18 years at the time of the earthquake. As the rate of pediatric thyroid cancer was higher than expected, we conducted biological dose assessment based on the frequency of translocated chromosome (Tr) aberrations using peripheral blood lymphocytes. Tr formation frequency was compared among the thyroid cancer (n = 38, median age 18 years, age range 12-26 years), thyroid-related disease (n = 30, median age 21 years, age range 15-28 years), and healthy controls (n = 31, median age 22 years, age range 20-23 years) groups. Tr aberration frequency was initially significantly higher in the thyroid cancer than in the other two groups; however, differences among the groups disappeared after adjusting for history of CT scan, as 92%, 67%, and 28% of those in the thyroid cancer, thyroid-related disease, and control groups, respectively, had undergone CT previously. Therefore, the significant difference in the initial number of Tr formations is presumably due to radiation exposure from CT. Accordingly, the effects of medical exposure on the chromosomes of children and adolescents should be noted.

Indexed as

Fukushima Nuclear AccidentRadiation ExposureThyroid NeoplasmsAdolescentAdultChildChromosome AberrationsHumansRadiation, IonizingYoung Adult

Identifiers

PMID37652956
PMCPMC10471584
OpenAlexW4386308113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.